When was Delphinus Medical Technologies founded?

Delphinus Medical Technologies was founded in 2010.

Where is Delphinus Medical Technologies located?

Delphinus Medical Technologies is headquartered in Plymouth, United States. It is registered at Novi, Michigan.

How many employees does Delphinus Medical Technologies have?

As of Apr 03, 2025, the latest employee count at Delphinus Medical Technologies is 61.

Is Delphinus Medical Technologies a funded company?

Delphinus Medical Technologies is a funded company, having raised a total of $137M across 15 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round.

When was the latest funding round of Delphinus Medical Technologies?

Delphinus Medical Technologies' latest funding was a $***** Series D round on Mar 22, 2024, with participation from 0 investor. Its primary sector is Women Health. In United States, the Women Health sector has seen $151M in funding in 2026 to date.

Where does Delphinus Medical Technologies rank among its competitors?

Delphinus Medical Technologies ranks 7th amongst 67 active competitors, of which 17 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was iSono Health, which secured an undisclosed amount in Oct, 2025.

Who are the top competitors of Delphinus Medical Technologies?

Delphinus Medical Technologies' top competitors include Wixsite, QT Imaging and iSono Health. Among them, iSono Health secured the most recent funding round in October, 2025.

Delphinus Medical Technologies - 2026 Company Profile, Team, Funding & Competitors

Delphinus Medical Technologies is a series D company based in Plymouth (United States), founded in 2010 by Neb Duric. It operates as a Platform for breast ultrasound imaging. Delphinus Medical Technologies has raised $137M in funding from Beringea and Venture Investors. The company has 67 active competitors, including 17 funded and 7 that have exited. Its top competitors include companies like Wixsite, QT Imaging and iSono Health.

Company Details

Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women’s breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.

Website: delphinusmt.com
Registered Address: Novi, Michigan

Key Metrics

Founded Year

2010

Location

Plymouth, United States

Stage

Series D

Total Funding

$137M in 15 rounds

Latest Funding Round

Series D, Mar 22, 2024, $*****

Investors

Beringea & 12 more

Ranked

7^th among 67 active competitors

Employee Count

61 as on Apr 03, 2025

Similar Companies

iSono Health & 28 more

View Delphinus Medical Technologies' full profile

Delphinus Medical Technologies is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DELPHINUS MEDICAL TECHNOLOGIES CIN: 272555762 , United States, Active	Dec 26, 999	-	46 (As on Dec 31, 2024)	-

Delphinus Medical Technologies has raised a total funding of $137M over 15 rounds. Delphinus Medical Technologies has 13 institutional investors.

Here is the list of recent funding rounds of Delphinus Medical Technologies:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 22, 2024	4015357	Series D	2761089	6715873	2872377	8768293
Aug 22, 2023	8872000	Venture Debt	7639950	3033746	3323995	Trinity Capital
Jun 30, 2023	2180381	Series D	9356156	5820482	3521167	2984056

Access funding benchmarks and valuations. Sign up today!

View details of Delphinus Medical Technologies's funding rounds and investors

The founders of Delphinus Medical Technologies is Neb Duric.

Here are the details of Delphinus Medical Technologies' key team members:

Neb Duric: Co-Founder & Chief Technology Officer of Delphinus Medical Technologies.

View details of Delphinus Medical Technologies's Founder profiles and Board Members

Delphinus Medical Technologies' employee count trend

Delphinus Medical Technologies has 61 employees as of Apr 25. Here is Delphinus Medical Technologies's employee count trend over the years:

Employee count trend for Delphinus Medical Technologies

Uncover Delphinus Medical Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Delphinus Medical Technologies include Wixsite, QT Imaging and iSono Health. Here is the list of Top 10 competitors of Delphinus Medical Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Wixsite 2012, Norway, Deadpooled	Provider of tools enabling users to create and manage websites	-	WatchTower & Friends, JLABS & 9 others	61/100
2nd	QT Imaging 2012, Novato (United States), Public	Developer of a non-invasive ultrasound imaging device for detecting breast cancer	$28.8M	GigCapital, Proud.Ventures & 4 others	59/100
3rd	iSono Health 2014, San Francisco (United States), Seed	Provider of AI-based 3D wearable device for early breast cancer detection	$1.96M	jskinvestments.cz, Y Combinator & 9 others	58/100
4th	Vayyar 2011, Yehud (Israel), Series E	Developer of 4D imaging sensors for cancer detection and other devices	$296M	Celesta Capital, Koch Disruptive Technologies ... & 17 others	55/100
5th	Koning 2002, United States, Funding Raised	Innovating breast imaging with advanced 3D CT technology	-	Defense.gov, National Cancer Institute & 5 others	54/100
6th	CairnSurgical 2015, Lebanon (United States), Series A	Developer of 3D printed surgical guides for breast cancer treatment	$7.79M	Morningside Ventures, Morningside & 5 others	54/100
7th	Delphinus Medical Technologies 2010, Plymouth (United States), Series D	Platform for breast ultrasound imaging	$137M	Trinity Capital, InvestMichigan! & 11 others	51/100
8th	Olive Healthcare 2016, Seoul (South Korea), Series B	Provider of device for wellness and medical purpose	$10.2M	Partners Investment, Korea Investment Holdings ... & 9 others	48/100
9th	UE LifeSciences 2009, Philadelphia (United States), Series A	Provider of a non-invasive breast cancer scanning device	$4.76M	Aarin Capital, Capria & 3 others	47/100
10th	CMR Naviscan 1995, San Diego (United States), Acquired	Develops and manufactures organ-specific molecular imaging technology solutions.	$29.8M	QuestMark Partners, Sanderling Ventures & 2 others	45/100